What is Haleon’s (HLN) updated share capital and voting rights?

Following these buybacks, Haleon’s registered share capital is 8,919,824,040 ordinary shares of £0.01 each. Of these, 12,439,998 are treasury shares, leaving 8,907,384,042 ordinary shares with voting rights for use in regulatory disclosure calculations.

Haleon (NYSE: HLN) repurchases 7.7M shares and updates voting stock

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

6-K

Rhea-AI Filing Summary

Haleon plc reported purchases of 7,740,513 ordinary shares of £0.01 each for cancellation under its share buyback programme announced on 12 March 2026. The shares were bought on multiple UK trading venues between 7 and 10 April 2026 at prices around the mid‑370p range.

After settlement, Haleon’s registered share capital is 8,919,824,040 ordinary shares, of which 12,439,998 are held as treasury shares. This leaves 8,907,384,042 ordinary shares with voting rights, a figure shareholders can use when assessing disclosure thresholds under the FCA’s transparency rules.

Key Figures

Shares repurchased: 7,740,513 shares Registered share capital: 8,919,824,040 shares Treasury shares: 12,439,998 shares +4 more

7 metrics

Shares repurchased 7,740,513 shares Ordinary shares bought for cancellation under March 2026 buyback

Registered share capital 8,919,824,040 shares Ordinary shares of £0.01 each after settlement of buybacks

Treasury shares 12,439,998 shares Ordinary shares held in treasury after transactions

Shares with voting rights 8,907,384,042 shares Ordinary shares carrying voting rights post buyback

Highest price paid 376.1000 pence Maximum per-share price reported on London Stock Exchange

Lowest price paid 361.6000 pence Minimum per-share price reported over the purchase dates

VWAP example 371.5015 pence Volume weighted average price on London Stock Exchange, 7 April 2026

Key Terms

treasury shares, share buyback programme, Market Abuse Regulation, Disclosure Guidance and Transparency Rules, +1 more

5 terms

treasury shares financial

"of which 12,439,998 are held as treasury shares."

Treasury shares are a company’s own stock that it has repurchased and keeps on its books instead of canceling or leaving in the hands of outside investors. Think of them like coupons a business puts back in a drawer: they don’t vote or receive dividends while held, but they can be reissued later for employee pay or fundraising. For investors this matters because buybacks change the number of shares that count toward earnings and ownership, can boost per‑share metrics, and use corporate cash that might otherwise go to growth or dividends.

Market Abuse Regulation regulatory

"In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 as it applies in the UK (the Market Abuse Regulation)"

Market abuse regulation consists of laws and rules designed to prevent dishonest or manipulative practices in financial markets. It aims to ensure fair and transparent trading, so investors can trust that markets operate honestly, much like rules that keep a game fair. By reducing unfair advantages, it helps protect investor confidence and promotes healthy, efficient markets.

Disclosure Guidance and Transparency Rules regulatory

"to notify their interest, or a change to their interest, in Haleon under the FCA's Disclosure Guidance and Transparency Rules."

Disclosure guidance and transparency rules are the standards and regulations that require companies to share clear, timely information about their finances, risks, operations and material events. They matter to investors because consistent, honest reporting is like a car’s dashboard — it reveals the data you need to judge safety and performance and make informed buying or selling decisions. Strong disclosure reduces surprises and helps keep markets fair and efficient.

ordinary shares financial

"ordinary shares of £0.01 each in the Company (the "Shares") for cancellation"

Ordinary shares are a type of ownership stake in a company, giving shareholders a right to participate in the company’s profits and decision-making through voting. They are similar to owning a piece of a business, and their value can rise or fall based on the company's performance. Investors buy ordinary shares to potentially earn dividends and benefit from the company's growth over time.

Form 6-K: How Foreign Companies Report to the SEC →

04/13/2026 - 06:41 AM

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of April 2026

Commission File Number: 001-41411

Haleon plc

(Translation of registrant’s name into English)

Building 5, First Floor, The Heights,

Weybridge, Surrey, KT13 0NY

(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

Form 20-F ☒

Form 40-F ☐

EXHIBIT INDEX

Exhibit Number	Description
99.1	13 April 2026 - “Transactions in Own Shares”

99.1

Haleon plc: Aggregated information - transactions in own shares

13 April 2026: Haleon plc (the "Company" or "Haleon") today announces the purchase of 7,740,513 ordinary shares of £0.01 each in the Company (the "Shares") for cancellation under its share buyback programme announced on 12 March 2026.

	London Stock Exchange	CBOE (UK)/BXE	CBOE (UK)/CXE	Aquis
Date of purchase:	7 April 2026
Number of Shares purchased:	888,210	615,286	787,828	-
Highest price paid per Share (p):	376.1000	376.0000	376.0000	-
Lowest price paid per Share (p):	367.5000	367.6000	367.5000	-
Volume weighted average price paid per Share (p):	371.5015	371.3255	371.6528	-
Date of purchase:	8 April 2026
Number of Shares purchased:	995,159	509,180	495,387	-
Highest price paid per Share (p):	375.0000	372.0000	372.0000	-
Lowest price paid per Share (p):	368.2000	368.3000	368.3000	-
Volume weighted average price paid per Share (p):	370.4762	370.2369	370.4203	-
Date of purchase:	9 April 2026
Number of Shares purchased:	1,583,132	911,974	497,143	-
Highest price paid per Share (p):	366.4000	366.4000	366.4000	-
Lowest price paid per Share (p):	361.6000	361.6000	362.4000	-
Volume weighted average price paid per Share (p):	363.1091	363.0479	363.6388	-
Date of purchase:	10 April 2026
Number of Shares purchased:	194,408	115,163	147,643	-
Highest price paid per Share (p):	367.2000	367.2000	367.2000	-
Lowest price paid per Share (p):	364.8000	364.8000	364.8000	-
Volume weighted average price paid per Share (p):	366.2767	366.1567	366.1972	-

Following the settlement of the above, the Company's registered share capital is 8,919,824,040 ordinary shares of £0.01 each, of which 12,439,998 are held as treasury shares. Therefore, the number of ordinary shares with voting rights is 8,907,384,042 and this figure may be used by shareholders to determine if they are required to notify their interest, or a change to their interest, in Haleon under the FCA's Disclosure Guidance and Transparency Rules.

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 as it applies in the UK (the Market Abuse Regulation), a full breakdown of the individual trades is available at the link below:

http://www.rns-pdf.londonstockexchange.com/rns/0713A_1-2026-4-10.pdf

This announcement does not constitute, or form part of, an offer or any solicitation of an offer for securities in any jurisdiction.

This announcement and individual trade breakdown will also be available on the Company's website at: www.haleon.com/investors.

Enquiries
Investors		Media
Jo Russell	+44 7787 392441	Zoë Bird	+44 7736 746167
Rakesh Patel	+44 7552 484646	Victoria Durman	+44 7894 505730
Email: investor-relations@haleon.com		Email: corporate.media@haleon.com

About Haleon

Haleon (LSE/NYSE: HLN) is a consumer company that is solely focused on better everyday health. Our people, our brands, our research, our investment and our innovation are aimed at improving the everyday health of consumers. Our product portfolio spans six major categories - Oral Health, Vitamins, Minerals and Supplements (VMS), Pain Relief, Respiratory Health, Digestive Health and Therapeutic Skin Health and Other. Our superior brands - such as Advil, Centrum, Otrivin, Panadol, parodontax, Polident, Sensodyne, Theraflu and Voltaren - are trusted by more than one billion consumers and are recommended by health professionals around the world.

For more information, please visit www.haleon.com.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

		HALEON PLC (Registrant)
Date: April 13, 2026	By:	/s/ Amanda Mellor
		Name:	Amanda Mellor
		Title:	Company Secretary

Source: View Original Filing on SEC EDGAR

FAQ

What did Haleon (HLN) announce in this April 2026 report?

Haleon announced it purchased 7,740,513 ordinary shares for cancellation under its share buyback programme. The trades took place across several UK trading venues between 7 and 10 April 2026 as part of the previously announced repurchase plan.

How many Haleon (HLN) shares were repurchased and cancelled?

Haleon repurchased 7,740,513 ordinary shares of £0.01 each for cancellation. These shares were bought in multiple daily tranches on UK venues including the London Stock Exchange, CBOE UK platforms and Aquis between 7 and 10 April 2026.

Where can investors find Haleon’s detailed trade breakdown?

Investors can access a full breakdown of the individual buyback trades via a linked RNS PDF on the London Stock Exchange website. The announcement and trade details are also available on Haleon’s own investor relations site at www.haleon.com/investors.

What price range did Haleon (HLN) pay for its repurchased shares?

Across the different trading venues and days, Haleon’s highest reported purchase prices reached around 376.1 pence per share and the lowest around 361.6 pence. Volume-weighted average prices generally clustered near the low‑ to mid‑370 pence level.

Does this Haleon announcement involve an offer of new securities?

No, the announcement explicitly states it does not constitute or form part of an offer or solicitation to sell securities. It strictly reports repurchases of existing shares for cancellation under the company’s ongoing share buyback programme.

What type of business is Haleon (HLN)?

Haleon is a consumer health company focused on improving everyday health. Its portfolio covers six categories, including Oral Health, Vitamins, Pain Relief, Respiratory, Digestive and Therapeutic Skin Health, featuring brands such as Sensodyne, Panadol, Advil, Voltaren, Centrum and Theraflu.